scorecardresearch
Add as a preferred source on Google
Wednesday, November 5, 2025
TopicDr. Reddy

Topic: Dr. Reddy

Dr Reddy’s sees short-lived boom for Merck’s Covid pills in India

Even as oral Covid pills from Merck, Pfizer are being seen as game changers, generic drugmakers are getting a reality check that there may not be too much money on the table.

Dr Reddy’s inks licensing pact with Eli Lilly for Covid treatment drug Baricitinib

The agreement between the two firms comes days after Eli Lilly signed voluntary licensing agreements with Indian drug companies— Sun Pharma, Cipla and Lupin.

Dr. Reddy’s pushes for immediate right to sell suboxone copies

Indivior Plc’s Suboxone Film is the leading opioid addiction treatment in US.

On Camera

Pakistan can’t bomb or bargain its way out of the TTP-TLP mess

Among the many problems Pakistan is currently dealing with, the TLP and TTP offer two varying dimensions of the same one.

Kerala’s silent startup surge—work near home, smooth roads, fast internet & diaspora engagement

Once seen as a fading presence on India’s investment & startup picture, the state is slowly moving up the ladder, with policy reforms & infrastructure building.

India & Israel ink agreement to share, co-develop & co-produce advanced defence tech

Agreement signed during 17th Joint Working Group (JWG) on defence cooperation. Defence Secretary Rajesh Kumar Singh met Director General in Israeli Ministry of Defence Amir Baram Tuesday. 

Trump’s trade wars have rewritten powerplay, but India didn’t get the memo

This world is being restructured and redrawn by one man, and what’s his power? It’s not his formidable military. It’s trade. With China, it turned on him.